Results
|
|
1.
|
Immunophenotypic features of acute myeloid leukemia with inv(3)(q21q26.2)/t(3;3)(q21;q26.2). [electronic resource] by
- Medeiros, Bruno C
- Kohrt, Holbrook E
- Arber, Daniel A
- Bangs, Charles D
- Cherry, Athena M
- Majeti, Ravindra
- Kogel, Karen E
- Azar, Catherine A
- Patel, Samit
- Alizadeh, Ash A
Producer: 20100423
In:
Leukemia research vol. 34
Availability: No items available.
|
|
|
2.
|
Phase III trial assessing bevacizumab in stages II and III carcinoma of the colon: results of NSABP protocol C-08. [electronic resource] by
- Allegra, Carmen J
- Yothers, Greg
- O'Connell, Michael J
- Sharif, Saima
- Petrelli, Nicholas J
- Colangelo, Linda H
- Atkins, James N
- Seay, Thomas E
- Fehrenbacher, Louis
- Goldberg, Richard M
- O'Reilly, Seamus
- Chu, Luis
- Azar, Catherine A
- Lopa, Samia
- Wolmark, Norman
Producer: 20110215
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 29
Availability: No items available.
|
|
|
3.
|
Initial safety report of NSABP C-08: A randomized phase III study of modified FOLFOX6 with or without bevacizumab for the adjuvant treatment of patients with stage II or III colon cancer. [electronic resource] by
- Allegra, Carmen J
- Yothers, Greg
- O'Connell, Michael J
- Sharif, Saima
- Colangelo, Linda H
- Lopa, Samia H
- Petrelli, Nicholas J
- Goldberg, Richard M
- Atkins, James N
- Seay, Thomas E
- Fehrenbacher, Louis
- O'Reilly, Seamus
- Chu, Luis
- Azar, Catherine A
- Wolmark, Norman
Producer: 20090916
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 27
Availability: No items available.
|
|
|
4.
|
Definitive results of a phase III adjuvant trial comparing three chemotherapy regimens in women with operable, node-positive breast cancer: the NSABP B-38 trial. [electronic resource] by
- Swain, Sandra M
- Tang, Gong
- Geyer, Charles E
- Rastogi, Priya
- Atkins, James N
- Donnellan, Paul P
- Fehrenbacher, Louis
- Azar, Catherine A
- Robidoux, André
- Polikoff, Jonathan A
- Brufsky, Adam M
- Biggs, David D
- Levine, Edward A
- Zapas, John L
- Provencher, Louise
- Northfelt, Donald W
- Paik, Soonmyung
- Costantino, Joseph P
- Mamounas, Eleftherios P
- Wolmark, Norman
Producer: 20131122
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 31
Availability: No items available.
|
|
|
5.
|
Lapatinib as a component of neoadjuvant therapy for HER2-positive operable breast cancer (NSABP protocol B-41): an open-label, randomised phase 3 trial. [electronic resource] by
- Robidoux, André
- Tang, Gong
- Rastogi, Priya
- Geyer, Charles E
- Azar, Catherine A
- Atkins, James N
- Fehrenbacher, Louis
- Bear, Harry D
- Baez-Diaz, Louis
- Sarwar, Shakir
- Margolese, Richard G
- Farrar, William B
- Brufsky, Adam M
- Shibata, Henry R
- Bandos, Hanna
- Paik, Soonmyung
- Costantino, Joseph P
- Swain, Sandra M
- Mamounas, Eleftherios P
- Wolmark, Norman
Producer: 20131227
In:
The Lancet. Oncology vol. 14
Availability: No items available.
|
|
|
6.
|
Seven-year follow-up assessment of cardiac function in NSABP B-31, a randomized trial comparing doxorubicin and cyclophosphamide followed by paclitaxel (ACP) with ACP plus trastuzumab as adjuvant therapy for patients with node-positive, human epidermal growth factor receptor 2-positive breast cancer. [electronic resource] by
- Romond, Edward H
- Jeong, Jong-Hyeon
- Rastogi, Priya
- Swain, Sandra M
- Geyer, Charles E
- Ewer, Michael S
- Rathi, Vikas
- Fehrenbacher, Louis
- Brufsky, Adam
- Azar, Catherine A
- Flynn, Patrick J
- Zapas, John L
- Polikoff, Jonathan
- Gross, Howard M
- Biggs, David D
- Atkins, James N
- Tan-Chiu, Elizabeth
- Zheng, Ping
- Yothers, Greg
- Mamounas, Eleftherios P
- Wolmark, Norman
Producer: 20130304
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 30
Availability: No items available.
|